Inquiries in Britain uncover loopholes in drug trials.
Rosenthal
Elisabeth
E
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D017321:Clinical Trials, Phase I as Topic / Q000009:adverse effects* / Q000331:legislation & jurisprudence / Q000592:standards; D004345:Drug Industry; D015507:Drugs, Investigational / Q000009:adverse effects*; D006801:Humans; D008131:London; D008297:Male; D009102:Multiple Organ Failure / Q000139:chemically induced; D033281:Nontherapeutic Human Experimentation; D012107:Research Design; D035842:Research Subjects; D006113:United Kingdom
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015507:Drugs, Investigational; C509303:TGN-1412